508. Bone Marrow Failure: Acquired: Poster I

Navigating the complement cascade A multicenter journey from pegcetacoplan to iptacopan in paroxysmal nocturnal hemoglobinuria

Epidemiologic clues current management and diagnostic trends in idiopathic budd chiari syndrome Implications of PNH and diagnostic testing

Management of a real world cohort of patients with paroxysmal nocturnal hemoglobinuria treated with iptacopan A multi institutional analysis

Real world treatment patterns and clinical outcomes among patients with paroxysmal nocturnal hemoglobinuria treated with iptacopan in the United States

Real world use of oral iptacopan monotherapy in paroxysmal nocturnal hemoglobinuria

Eltrombopag promotes hematopoietic engraftment and improves the survival of bone marrow failure disease following hematopoietic stem cell transplantation

Evaluation of current diagnostic workup for pediatric severe aplastic anemia Low incidence of cryptic inherited bone marrow failure syndromes

Aplastic anemia in pregnancy A case series review of hematologic parameters treatment and maternal fetal outcomes

Rare germline complement gene variants in severe aplastic anemia

Efficacy and safety of pozelimab plus cemdisiran versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria who received prior C5 therapy

Iron overload and iron chelation therapy in PNH patients on complement inhibitors A single centre experience

Development and validation of the predictive aplastic score system PASS A simplified tool to diagnose acquired aplastic anemia in adults

DNA methylation variability in pediatric aplastic anemia contributes to T cell differentiation

Real world application of AI in expediting paroxysmal nocturnal hemoglobinuria diagnosis

Beyond the unknown Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort